首页> 美国卫生研究院文献>Journal of the American Medical Informatics Association : JAMIA >SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care
【2h】

SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care

机译:SMART精准抗癌药物:基于FHIR的应用程序可在护理点提供基因组信息

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background Precision cancer medicine (PCM) will require ready access to genomic data within the clinical workflow and tools to assist clinical interpretation and enable decisions. Since most electronic health record (EHR) systems do not yet provide such functionality, we developed an EHR-agnostic, clinico-genomic mobile app to demonstrate several features that will be needed for point-of-care conversations. >Methods Our prototype, called Substitutable Medical Applications and Reusable Technology (SMART)® PCM, visualizes genomic information in real time, comparing a patient’s diagnosis-specific somatic gene mutations detected by PCR-based hotspot testing to a population-level set of comparable data. The initial prototype works for patient specimens with 0 or 1 detected mutation. Genomics extensions were created for the Health Level Seven® Fast Healthcare Interoperability Resources (FHIR)® standard; otherwise, the prototype is a normal SMART on FHIR app. >Results The PCM prototype can rapidly present a visualization that compares a patient’s somatic genomic alterations against a distribution built from more than 3000 patients, along with context-specific links to external knowledge bases. Initial evaluation by oncologists provided important feedback about the prototype’s strengths and weaknesses. We added several requested enhancements and successfully demonstrated the app at the inaugural American Society of Clinical Oncology Interoperability Demonstration; we have also begun to expand visualization capabilities to include cancer specimens with multiple mutations. >Discussion PCM is open-source software for clinicians to present the individual patient within the population-level spectrum of cancer somatic mutations. The app can be implemented on any SMART on FHIR-enabled EHRs, and future versions of PCM should be able to evolve in parallel with external knowledge bases.
机译:>背景精准癌症医学(PCM)将需要随时访问临床工作流程中的基因组数据和工具,以协助临床解释和做出决策。由于大多数电子健康记录(EHR)系统尚未提供此类功能,因此我们开发了与EHR无关的临床基因组移动应用程序,以演示即时医疗对话所需的多种功能。 >方法我们的原型称为可替代医学应用和可重复使用技术(SMART)®PCM,可实时可视化基因组信息,将通过基于PCR的热点测试检测到的患者特定于诊断的体细胞基因突变与人群进行比较级可比数据集。初始原型适用于检测到0或1个突变的患者标本。基因组学扩展是针对Health LevelSeven®快速医疗保健互操作性资源(FHIR)®标准创建的;否则,原型是FHIR应用程序上的常规SMART。 >结果 PCM原型可以快速呈现可视化效果,该可视化效果将患者的体细胞基因组变化与3000多个患者建立的分布进行比较,并提供特定上下文的外部知识库链接。肿瘤学家的初步评估为原型的优缺点提供了重要的反馈。我们增加了一些要求的增强功能,并在美国临床肿瘤学会互操作性演示会上成功演示了该应用程序;我们还开始扩展可视化功能,以包括具有多个突变的癌症标本。 > Discussion (讨论) PCM是供临床医生使用的开源软件,可在癌症体细胞突变的人群水平范围内展示单个患者。可以在启用FHIR的EHR的任何SMART上实现该应用程序,并且PCM的未来版本应该能够与外部知识库并行发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号